The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors.

Authors:
Fallarini S; Bhela IP; Aprile S; Torre E; Ranza A and 6 more

Journal:
ChemMedChem

Publication Year: 2021

DOI:
10.1002/cmdc.202100446

PMCID:
PMC9291769

PMID:
34355531

Journal Information

Full Title: ChemMedChem

Abbreviation: ChemMedChem

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"M. S. is supported by Fondazione AIRC (Associazione Italiana per la Ricerca sul Cancro) fellowship for Abroad (Rif. 25278). T.P. and M.T.P. hold a grant from Ministero dell′Istruzione, dell′Università e della Ricerca (MIUR) (PRIN 2017 N° 2017WJZ9W9). Open Access Funding provided by Universita degli Studi del Piemonte Orientale Amedeo Avogadro within the CRUI‐CARE Agreement."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025